Works matching IS 02780232 AND DT 2022 AND VI 40 AND IP 5

Results: 34
    1
    2
    3

    Characteristics and clinical outcomes of patients with ALK‐positive anaplastic large cell lymphoma: Report from the prospective international T‐cell lymphoma project.

    Published in:
    Hematological Oncology, 2022, v. 40, n. 5, p. 953, doi. 10.1002/hon.3074
    By:
    • Chiattone, Carlos;
    • Civallero, Monica;
    • Fischer, Thais;
    • Miranda, Eliana;
    • Manni, Martina;
    • Zing, Natalia P. C.;
    • Pileri, Stefano A.;
    • Montoto, Silvia;
    • Horwitz, Steven M.;
    • Cabrera, Maria Elena;
    • De Souza, Carmino A.;
    • Nagler, Arnon;
    • Luminari, Stefano;
    • Ferreri, Andrés J. M.;
    • Carson, Kenneth R.;
    • Re, Alessandro;
    • Rigacci, Luigi;
    • Nassi, Luca;
    • Stepanishyna, Yana;
    • Federico, Massimo
    Publication type:
    Article
    4

    CCR7 alterations associated with inferior outcome of adult T‐cell leukemia/lymphoma under mogamulizumab treatment.

    Published in:
    Hematological Oncology, 2022, v. 40, n. 5, p. 876, doi. 10.1002/hon.3072
    By:
    • Sakamoto, Yuma;
    • Ishida, Takashi;
    • Masaki, Ayako;
    • Murase, Takayuki;
    • Ohtsuka, Eiichi;
    • Takeshita, Morishige;
    • Muto, Reiji;
    • Iwasaki, Hiromi;
    • Ito, Asahi;
    • Kusumoto, Shigeru;
    • Nakano, Nobuaki;
    • Tokunaga, Masahito;
    • Yonekura, Kentaro;
    • Tashiro, Yukie;
    • Iida, Shinsuke;
    • Utsunomiya, Atae;
    • Ueda, Ryuzo;
    • Inagaki, Hiroshi
    Publication type:
    Article
    5
    6
    7
    8

    NR1H3 (LXRα) is associated with pro‐inflammatory macrophages, predicts survival and suggests potential therapeutic rationales in diffuse large b‐cell lymphoma.

    Published in:
    Hematological Oncology, 2022, v. 40, n. 5, p. 864, doi. 10.1002/hon.3050
    By:
    • Vegliante, Maria Carmela;
    • Mazzara, Saveria;
    • Zaccaria, Gian Maria;
    • De Summa, Simona;
    • Esposito, Flavia;
    • Melle, Federica;
    • Motta, Giovanna;
    • Sapienza, Maria Rosaria;
    • Opinto, Giuseppina;
    • Volpe, Giacomo;
    • Bucci, Antonella;
    • Gargano, Grazia;
    • Enjuanes, Anna;
    • Tabanelli, Valentina;
    • Fiori, Stefano;
    • Minoia, Carla;
    • Clemente, Felice;
    • Negri, Antonio;
    • Gulino, Alessandro;
    • Morello, Gaia
    Publication type:
    Article
    9
    10

    The spectrum of subclonal TP53 mutations in chronic lymphocytic leukemia: A next generation sequencing retrospective study.

    Published in:
    Hematological Oncology, 2022, v. 40, n. 5, p. 962, doi. 10.1002/hon.3063
    By:
    • De Luca, Giuseppa;
    • Cerruti, Giannamaria;
    • Lastraioli, Sonia;
    • Conte, Romana;
    • Ibatici, Adalberto;
    • Di Felice, Nikki;
    • Morabito, Fortunato;
    • Monti, Paola;
    • Fronza, Gilberto;
    • Matis, Serena;
    • Colombo, Monica;
    • Fabris, Sonia;
    • Ciarrocchi, Alessia;
    • Neri, Antonino;
    • Menichini, Paola;
    • Ferrarini, Manlio;
    • Nozza, Paolo;
    • Fais, Franco;
    • Cutrona, Giovanna;
    • Dono, Mariella
    Publication type:
    Article
    11
    12

    Lack of efficacy of convalescent plasma in COVID‐19 patients with concomitant hematological malignancies: An Italian retrospective study.

    Published in:
    Hematological Oncology, 2022, v. 40, n. 5, p. 857, doi. 10.1002/hon.3060
    By:
    • Lanza, Francesco;
    • Monaco, Federica;
    • Ciceri, Fabio;
    • Cairoli, Roberto;
    • Sacchi, Maria Vittoria;
    • Guidetti, Anna;
    • Marchetti, Monia;
    • Massaia, Massimo;
    • Arcaini, Luca;
    • Krampera, Mauro;
    • Mohamed, Sara;
    • Gherlinzoni, Filippo;
    • Mecucci, Cristina;
    • Gentile, Massimo;
    • Romano, Ilaria;
    • Venditti, Adriano;
    • Ruggeri, Marco;
    • Ferrero, Dario;
    • Coviello, Elisa;
    • Fabbri, Elisabetta
    Publication type:
    Article
    13

    Prognostic impact of complex karyotype on post‐transplant outcomes of myelofibrosis.

    Published in:
    Hematological Oncology, 2022, v. 40, n. 5, p. 1076, doi. 10.1002/hon.3058
    By:
    • Okada, Yosuke;
    • Takenaka, Katsuto;
    • Murata, Makoto;
    • Shimazu, Yutaka;
    • Tachibana, Takayoshi;
    • Ozawa, Yukiyasu;
    • Uchida, Naoyuki;
    • Wakayama, Toshio;
    • Doki, Noriko;
    • Sugio, Yasuhiro;
    • Tanaka, Masatsugu;
    • Masuko, Masayoshi;
    • Kobayashi, Hikaru;
    • Ino, Kazuko;
    • Ishikawa, Jun;
    • Nakamae, Hirohisa;
    • Matsuoka, Ken‐ichi;
    • Kanda, Yoshinobu;
    • Fukuda, Takahiro;
    • Atsuta, Yoshiko
    Publication type:
    Article
    14
    15

    Comparison of efficacy and safety of ripertamab (SCT400) versus rituximab (Mabthera<sup>®</sup>) in combination with CHOP in patients with previously untreated CD20‐positive diffuse large B‐cell lymphoma: A randomized, single‐blind, phase III clinical trial

    Published in:
    Hematological Oncology, 2022, v. 40, n. 5, p. 930, doi. 10.1002/hon.3054
    By:
    • Shi, Yuankai;
    • Zhang, Qingyuan;
    • Hong, Xiaonan;
    • Wang, Zhen;
    • Gao, Yuhuan;
    • Zou, Liqun;
    • Cen, Hong;
    • Gui, Lin;
    • Li, Yufu;
    • Feng, Jifeng;
    • Wang, Zhao;
    • Zhang, Mingzhi;
    • Jin, Chuan;
    • Zhang, Weihua;
    • Hu, Jianda;
    • Zheng, Chengyun;
    • Zheng, Zhendong;
    • Zhang, Liling;
    • Chen, Shaoshui;
    • Huang, Yunhong
    Publication type:
    Article
    16

    Long‐term follow‐up and health‐related quality of life among cancer survivors with stage IEA orbital‐type lymphoma after external photon‐beam radiotherapy: Results from a longitudinal study.

    Published in:
    Hematological Oncology, 2022, v. 40, n. 5, p. 922, doi. 10.1002/hon.3053
    By:
    • Hoffmann, Christian;
    • Rating, Philipp;
    • Bechrakis, Nikolaos;
    • Eckstein, Anja;
    • Sokolenko, Ekaterina;
    • Jabbarli, Leyla;
    • Westekemper, Henrike;
    • Mohr, Christopher;
    • Schmeling, Claus;
    • Huettmann, Andreas;
    • von Tresckow, Julia;
    • Göricke, Sophia;
    • Deuschl, Cornelius;
    • Johansson, Patricia;
    • Poettgen, Christoph;
    • Gauler, Thomas;
    • Guberina, Nika;
    • Moliavi, Sourour;
    • Stuschke, Martin;
    • Guberina, Maja
    Publication type:
    Article
    17

    Secondary infections worsen the outcome of COVID‐19 in patients with hematological malignancies: A report from the ITA‐HEMA‐COV.

    Published in:
    Hematological Oncology, 2022, v. 40, n. 5, p. 846, doi. 10.1002/hon.3048
    By:
    • Zappasodi, Patrizia;
    • Cattaneo, Chiara;
    • Valeria Ferretti, Virginia;
    • Mina, Roberto;
    • José María Ferreri, Andrés;
    • Merli, Francesco;
    • Oberti, Margherita;
    • Krampera, Mauro;
    • Romano, Alessandra;
    • Zerbi, Caterina;
    • Ferrari, Jacqueline;
    • Cavo, Michele;
    • Salvini, Marco;
    • Bertù, Lorenza;
    • Stefano Fracchiolla, Nicola;
    • Marchesi, Francesco;
    • Massaia, Massimo;
    • Marasco, Vincenzo;
    • Cairoli, Roberto;
    • Maria Scattolin, Anna
    Publication type:
    Article
    18
    19

    Carfilzomib combined with lenalidomide and dexamethasone (KRd) as salvage therapy for multiple myeloma patients: italian, multicenter, retrospective clinical experience with 600 cases outside of controlled clinical trials.

    Published in:
    Hematological Oncology, 2022, v. 40, n. 5, p. 1009, doi. 10.1002/hon.3035
    By:
    • Martino, Enrica Antonia;
    • Conticello, Concetta;
    • Zamagni, Elena;
    • Pavone, Vincenzo;
    • Palmieri, Salvatore;
    • Musso, Maurizio;
    • Tacchetti, Paola;
    • Mele, Anna;
    • Catalano, Lucio;
    • Vigna, Ernesto;
    • Bruzzese, Antonella;
    • Mendicino, Francesco;
    • Botta, Cirino;
    • Vincelli, Iolanda Donatella;
    • Farina, Giuliana;
    • Barone, Marialucia;
    • Cangialosi, Clotilde;
    • Mancuso, Katia;
    • Rizziello, Ilaria;
    • Rocchi, Serena
    Publication type:
    Article
    20

    Isatuximab plus carfilzomib and dexamethasone versus carfilzomib and dexamethasone in elderly patients with relapsed multiple myeloma: IKEMA subgroup analysis.

    Published in:
    Hematological Oncology, 2022, v. 40, n. 5, p. 1020, doi. 10.1002/hon.3038
    By:
    • Facon, Thierry;
    • Moreau, Philippe;
    • Martin, Thomas G.;
    • Spicka, Ivan;
    • Oriol, Albert;
    • Koh, Youngil;
    • Lim, Andrew;
    • Mikala, Gabor;
    • Rosiñol, Laura;
    • Yağci, Münci;
    • Cavo, Michele;
    • Yong, Kwee;
    • Risse, Marie‐Laure;
    • Asset, Gaëlle;
    • Schwab, Sandrine;
    • Martinez, Gracia
    Publication type:
    Article
    21

    Adult patients with Ph+ ALL benefit from conditioning regimen of medium‐dose VP16 plus CY/TBI.

    Published in:
    Hematological Oncology, 2022, v. 40, n. 5, p. 1041, doi. 10.1002/hon.3046
    By:
    • Morita‐Fujita, Mari;
    • Arai, Yasuyuki;
    • Kondo, Tadakazu;
    • Harada, Kaito;
    • Uchida, Naoyuki;
    • Toya, Takashi;
    • Ozawa, Yukiyasu;
    • Fukuda, Takahiro;
    • Ota, Shuichi;
    • Onizuka, Makoto;
    • Kanda, Yoshinobu;
    • Maruyama, Yumiko;
    • Takada, Satoru;
    • Kawakita, Toshiro;
    • Ara, Takahide;
    • Ichinohe, Tatsuo;
    • Kimura, Takafumi;
    • Atsuta, Yoshiko;
    • Kako, Shinichi
    Publication type:
    Article
    22
    23

    Isolated intraocular relapses of primary cerebral lymphomas: An LOC network study.

    Published in:
    Hematological Oncology, 2022, v. 40, n. 5, p. 976, doi. 10.1002/hon.3044
    By:
    • Younan, Nadia;
    • Soussain, Carole;
    • Choquet, Sylvain;
    • Cassoux, Nathalie;
    • Touitou, Valérie;
    • Schmitt, Anna;
    • Chinot, Olivier;
    • Oberic, Lucie;
    • Damaj, Gandhi;
    • Houot, Roch;
    • Ghesquières, Hervé;
    • Laribi, Kamel;
    • Ahle, Guido;
    • Taillandier, Luc;
    • Paillassa, Jérôme;
    • Gyan, Emmanuel;
    • Jardin, Fabrice;
    • Delwail, Vincent;
    • Marolleau, Jean‐Pierre;
    • Tempescul, Adrian
    Publication type:
    Article
    24

    Pirarubicin‐based intensive chemotherapy followed by consolidative high‐dose chemotherapies for peripheral T‐cell lymphomas: A noncomparative phase 2 study.

    Published in:
    Hematological Oncology, 2022, v. 40, n. 5, p. 1094, doi. 10.1002/hon.3043
    By:
    • Takahashi, Hiromichi;
    • Miura, Katsuhiro;
    • Nakagawa, Masaru;
    • Nishimaki, Haruna;
    • Ito, Shun;
    • Nukariya, Hironao;
    • Kurihara, Kazuya;
    • Endo, Toshihide;
    • Koike, Takashi;
    • Hamada, Takashi;
    • Iizuka, Kazuhide;
    • Ohatake, Shimon;
    • Iriyama, Noriyoshi;
    • Nakayama, Tomohiro;
    • Masuda, Shinobu;
    • Hatta, Yoshihiro;
    • Nakamura, Hideki
    Publication type:
    Article
    25

    Network meta‐analysis of randomized trials in multiple myeloma: Efficacy and safety in frontline therapy for patients not eligible for transplant.

    Published in:
    Hematological Oncology, 2022, v. 40, n. 5, p. 987, doi. 10.1002/hon.3041
    By:
    • Botta, Cirino;
    • Gigliotta, Emilia;
    • Paiva, Bruno;
    • Anselmo, Rita;
    • Santoro, Marco;
    • Otero, Paula Rodriguez;
    • Carlisi, Melania;
    • Conticello, Concetta;
    • Romano, Alessandra;
    • Solimando, Antonio Giovanni;
    • Cerchione, Claudio;
    • Vià, Matteo Da;
    • Bolli, Niccolò;
    • Correale, Pierpaolo;
    • Di Raimondo, Francesco;
    • Gentile, Massimo;
    • San Miguel, Jesus;
    • Siragusa, Sergio
    Publication type:
    Article
    26
    27

    Anatomical heterogeneity of residual disease in chronic lymphocytic leukemia treated with ibrutinib.

    Published in:
    Hematological Oncology, 2022, v. 40, n. 5, p. 1105, doi. 10.1002/hon.3039
    By:
    • Condoluci, Adalgisa;
    • Milan, Lisa;
    • Forestieri, Gabriela;
    • Terzi di Bergamo, Lodovico;
    • Spina, Valeria;
    • Bruscaggin, Alessio;
    • Deambrogi, Clara;
    • Moia, Riccardo;
    • Deodato, Marina;
    • Fahrni, Gaby;
    • Mattarucchi, Roberta;
    • Merli, Michele;
    • Gerber, Bernhard;
    • Stussi, Georg;
    • Passamonti, Francesco;
    • Gregor, Michael;
    • Tedeschi, Alessandra;
    • Gaidano, Gianluca;
    • Rossi, Davide;
    • Ceriani, Luca
    Publication type:
    Article
    28
    29

    Ibrutinib dose intensity in high‐risk chronic lymphocytic leukemia.

    Published in:
    Hematological Oncology, 2022, v. 40, n. 5, p. 1100, doi. 10.1002/hon.3032
    By:
    • Forestieri, Gabriela;
    • Terzi di Bergamo, Lodovico;
    • Deodato, Marina;
    • Frustaci, Anna Maria;
    • Moia, Riccardo;
    • Deambrogi, Clara;
    • Rasi, Silvia;
    • Autore, Francesco;
    • Merli, Michele;
    • Mattarucchi, Roberta;
    • Fahrni, Gaby;
    • Scarfo', Lydia;
    • Gussetti, Daniela;
    • Bulian, Pietro;
    • Zanatta, Annagiulia;
    • Spina, Valeria;
    • Bruscaggin, Alessio;
    • Pini, Katia;
    • Piffaretti, Deborah;
    • Pirosa, Maria Cristina
    Publication type:
    Article
    30
    31
    32
    33
    34

    Issue Information.

    Published in:
    Hematological Oncology, 2022, v. 40, n. 5, p. 819, doi. 10.1002/hon.2893
    Publication type:
    Article